Japan – the world’s third biggest spender on healthcare, and the world’s second largest pharmaceutical market, is reforming its healthcare system – starting with drug price cuts, encouraging the use of generics and the introduction of a health technology assessment (HTA) system. How will recent policy changes impact Japan’s pharmaceutical market?
Sign up to receive future infographics and publications from EIU Healthcare.
